The Lancet Infectious Diseases Infectious Diseases
Second-season observations after prophylaxis in the evaluation of the impact of nirsevimab in Galicia (NIRSE-GAL) study: mechanistic interpretation and implications for respiratory syncytial virus prevention strategy
The publisher did not provide an abstract — full text is available via the link below.